Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

ClinicalTrials.gov ID: NCT00650091

Public ClinicalTrials.gov record NCT00650091. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 12:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Prednisone, Azathioprine, and N-acetylcysteine: A Study That Evaluates Response in IPF

Study identification

NCT ID
NCT00650091
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Duke University
Other
Enrollment
264 participants

Conditions and interventions

Interventions

  • N-acetylcysteine (NAC) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
35 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2009
Primary completion
Sep 30, 2013
Completion
Dec 31, 2013
Last update posted
Jun 1, 2015

2009 – 2014

United States locations

U.S. sites
26
U.S. states
21
U.S. cities
23
Facility City State ZIP Site status
University of Alabama - Birmingham Birmingham Alabama 35294
University of California - Los Angeles Los Angeles California 90095
University of California - San Francisco San Francisco California 94110
National Jewish Medical and Research Center Denver Colorado 80206
Yale University School of Medicine New Haven Connecticut 06520
University of Miami Miller School of Medicine Miami Florida 33136
University of Chicago Chicago Illinois 60637
University of Louisville Louisville Kentucky 40425
Tulane University New Orleans Louisiana 70118
Brigham and Women's Hospital Boston Massachusetts 02115
Beth Israel Deaconess Medical Center Boston Massachusetts 02215
University of Michigan Ann Arbor Michigan 48109
Mayo Clinic Rochester Minnesota 55905
St. Luke's Hospital Chesterfield Missouri 63107
Weill Medical College of Cornell University New York New York 10021
Mount Sinai Hospital New York New York 10029
Highland Hospital - University of Rochester Medical Center Rochester New York 14620
Duke Universtiy Durham North Carolina 27705
Cleveland Clinic Cleveland Ohio 44195
University of Pennsylvania Health System Philadelphia Pennsylvania 19104
Temple University Philadelphia Pennsylvania 19140
Medical University of South Carolina Charleston South Carolina 29425
Vanderbilt University Nashville Tennessee 37232
University of Texas Southwestern Medical Center Dallas Texas 75390
University of Utah Health Research Center Salt Lake City Utah 84108
University of Washington Seattle Washington 98165

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00650091, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2015 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00650091 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →